8-K
Current Report
MoonLake Immunotherapeutics Filed Acc 0001213900-25-106723
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading ea0264149-8k_moonlake.htm…